Vasoinhibins Prevent Bradykinin-Stimulated Endothelial Cell Proliferation by Inactivating eNOS via Reduction of both Intracellular Ca2+ Levels and eNOS Phosphorylation at Ser1179
Authors:
- Stéphanie ThebaultSTStéphanie Thebault
- Carmen GonzálezCGCarmen González
- Celina GarcíaCGCelina García
- David Arredondo ZamarripaDZDavid Arredondo Zamarripa
- Gabriel NavaGNGabriel Nava
- Luis VacaLVLuis Vaca
- Fernando López-CasillasFLFernando López-Casillas
- Gonzalo Martínez De la EscaleraGEGonzalo Martínez De la Escalera
- Carmen ClappCCCarmen Clapp
Open Access
- 20 July 2011
- journal article
- research article
- Published by MDPI AG in Pharmaceuticals
- Vol. 4 (7) , 1052-1069
Abstract
Vasoinhibins, a family of antiangiogenic peptides derived from prolactin proteolysis, inhibit the vascular effects of several proangiogenic factors, including bradykinin (BK). Here, we report that vasoinhibins block the BK-induced proliferation of bovine umbilical vein endothelial cells. This effect is mediated by the inactivation of endothelial nitric oxide synthase (eNOS), as the NO donor DETA-NONOate reverted vasoinhibin action. It is an experimentally proven fact that the elevation of intracellular Ca2+ levels ([Ca2+]i) upon BK stimulation activates eNOS, and vasoinhibins blocked the BK-mediated activation of phospholipase C and the formation of inositol 1,4,5-triphosphate leading to a reduced release of Ca2+ from intracellular stores. The [Ca2+]i rise evoked by BK also involves the influx of extracellular Ca2+ via canonical transient receptor potential (TRPC) channels. Vasoinhibins likely interfere with TRPC-mediated Ca2+ entry since La3+, which is an enhancer of TRPC4 and TRPC5 channel activity, prevented vasoinhibins from blocking the stimulation by BK of endothelial cell NO production and proliferation, and vasoinhibins reduced the BK-induced increase of TRPC5 mRNA expression. Finally, vasoinhibins prevented the BK-induced phosphorylation of eNOS at Ser1179, a post-translational modification that facilitates Ca2+-calmodulin activation of eNOS. Together, our data show that vasoinhibins, by lowering NO production through the inhibition of both [Ca2+]i mobilization and eNOS phosphorylation, prevent the BK-induced stimulation of endothelial cell proliferation. Thus, vasoinhibins help to regulate BK effects on angiogenesis and vascular homeostasis.Keywords
This publication has 52 references indexed in Scilit:
- High Levels of Serum Prolactin Protect Against Diabetic Retinopathy by Increasing Ocular VasoinhibinsDiabetes, 2010
- Nitric oxide lacks direct effect on TRPC5 channels but suppresses endogenous TRPC5-containing channels in endothelial cellsPflügers Archiv - European Journal of Physiology, 2010
- Regulation of Ca2+ entry by inositol lipids in mammalian cells by multiple mechanismsCell Calcium, 2009
- Silencing TRPM7 promotes growth/proliferation and nitric oxide production of vascular endothelial cells via the ERK pathwayCardiovascular Research, 2009
- Effects of Combined Phosphorylation at Ser-617 and Ser-1179 in Endothelial Nitric-oxide Synthase on EC50(Ca2+) Values for Calmodulin Binding and Enzyme ActivationJournal of Biological Chemistry, 2009
- Vasoinhibins prevent retinal vasopermeability associated with diabetic retinopathy in rats via protein phosphatase 2A–dependent eNOS inactivationJournal of Clinical Investigation, 2008
- Retinal plasma extravasation in streptozotocin‐diabetic rats mediated by kinin B1and B2receptorsBritish Journal of Pharmacology, 2008
- The phosphorylation state of eNOS modulates vascular reactivity and outcome of cerebral ischemia in vivoJournal of Clinical Investigation, 2007
- Store-Operated Calcium ChannelsPhysiological Reviews, 2005
- Mass measurements of inositol(1,4,5)trisphosphate in rat cerebral cortex slices using a radioreceptor assay: Effects of neurotransmitters and depolarizationBiochemical and Biophysical Research Communications, 1988